Oslo, Norway

Alan Peter Clarke

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 1.9

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Alan Peter Clarke: Innovator in Radiochemistry

Introduction

Alan Peter Clarke is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of radiochemistry, particularly in the development of injectable compositions. With a total of 5 patents to his name, Clarke's work has advanced the methods of synthesis and purification in this specialized area.

Latest Patents

Clarke's latest patents include innovative methods that enhance the efficiency of radiolabelling processes. One of his key inventions is the "Solid phase purification," which provides a method for synthesizing an injectable composition comprising a [F]-labelled pyridaben derivative that is amenable to automation. This method utilizes solid phase extraction (SPE) for purification, streamlining the process significantly. Another important patent is the "Stabilized radiolabelling reaction," which offers a more advantageous method for synthesizing the same injectable composition. This method allows for easier purification using solid phase extraction, improving upon prior techniques.

Career Highlights

Clarke is currently associated with GE Healthcare Limited, where he continues to innovate and contribute to advancements in medical technology. His work is pivotal in enhancing the quality and efficiency of radiochemical applications in healthcare.

Collaborations

Clarke has collaborated with talented individuals such as Torgrim Engell and Alexander Jackson, further enriching his research and development efforts.

Conclusion

Alan Peter Clarke's contributions to the field of radiochemistry through his patents and work at GE Healthcare Limited highlight his role as a significant innovator. His advancements in synthesis and purification methods are set to impact the medical field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…